Abstract:Novel thermomechanical hydrogel scaffolds containing our previously prepared microspheres loaded with bone morphogenetic proteins (BMP) were successfully generated by radical crosslinking and low dose γ-irradiation from combination of two kind of biomaterials: glycidyl methacrylated dextran (Dex-GMA) and gelatin. The structure of those resulting smart hybrid hydrogels was evaluated by mercury intrusion porosimetry (MIP) and scanning electron microscopy (SEM) analyses, and as a function of the degree of Dex-GMA's substitution (DS), the proportion between Dex-GMA and gelatin, and the initial polyethyleneglycol (PEG) concentration used in the preparation of the hydrogels. The swelling and degradation properties and the temperature-sensitive drug release manner were determined by dynamic evaluation methods in vitro, and the gel content was also calculated. MIP analysis showed that by systematically altering the preparation parameters, the overall networks were clearly macroporous with pore sizes ranging from 5.6±4.2 to 37.7±13.7 μm. As expected, the pore size decreased as DS and initial PEG concentration increased, whereas the opposite was found for the gel content. Moreover, the porosity values ranged from 73.7±12.4% up to 89.6±6.3%. The SEM results also showed the inter-connective pores as well as microspheres encased into their porous structure of those hydrogels. The swelling and degradation properties of the resultant hydrogels varied according to the DS of Dex-GMA and initial PEG concentration, while the proportion between Dex-GMA and gelatin had no significant influence on those characterizations. By changing the composition ratio of the two precursors, the phase transition temperature (lower critical solution temperature, LSCT) of the hydrogel scaffolds could also be adjusted to be or near the body temperature, so BMP release from microsphere–hydrogel compounds could be accordingly controlled and the release period could be varied from 18 to more than 28 days. These results demonstrated that a novel temperature-sensitive and biodegradable Dex-GMA/gelatin scaffold containing microspheres loaded with BMP could be successfully developed from both dextran- and gelatin-based biomaterials, which could promisingly satisfy the need, desire, and expectation of both self-regulated drug delivery and tissue-engineering applications.

Injectable hydrogels embedded with alginate microspheres for controlled delivery of bone morphogenetic protein-2.

In vitro sustained release of recombinant human bone morphogenetic protein-2 microspheres embedded in thermosensitive hydrogels

Chitosan-Based Hydrogels Embedded with Hyaluronic Acid Complex Nanoparticles for Controlled Delivery of Bone Morphogenetic Protein-2

Click-based injectable bioactive PEG-hydrogels guide rapid craniomaxillofacial bone regeneration by the spatiotemporal delivery of rhBMP-2

Locally Controlled Diffusive Release of Bone Morphogenetic Protein-2 Using Micropatterned Gelatin Methacrylate Hydrogel Carriers

Enhancement of Bone Formation by Bone Morphogenetic Protein-2 Released from Poly (L-Lactic-co-glycolic Acid) Microsphere

Sustained release of rhBMP-2 from microporous tricalciumphosphate using hydrogels as a carrier

An injectable carboxymethyl chitosan-based hydrogel with controlled release of BMP-2 for efficient treatment of bone defects

Preparation and Biological Characteristics of Recombinant Human Bone Morphogenetic Protein-2-Loaded Dextran-co-Gelatin Hydrogel Microspheres, in Vitro and in Vivo Studies

PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis

Biomimetic ECM coatings for controlled release of rhBMP-2: construction and biological evaluation

Efficient Delivery of Recombinant Human Bone Morphogenetic Protein (Rhbmp-2) with Dextran Sulfate-Chitosan Microspheres

Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.

Preparation of Recombinant Human Bone Morphogenetic Protein-2 Loaded Dextran-Based Microspheres and Their Characteristics

Preparation of Recombinant Human Bone Morphogenetic Protein-2 Sustained Release Hydrogel Microspheres, and in Vitro Studies of Their Swelling, Biodegradation, Drug Loading and Release

Preparation and evaluation of recombinant human bone morphogenetic protein-2 loaded microsphere

In situ controlled release of rhBMP-2 in gelatin-coated 3D porous poly(ε-caprolactone) scaffolds for homogeneous bone tissue formation.

In Situ Controlled Release Of Rhbmp-2 In Gelatin-Coated 3d Porous Poly(Epsilon-Caprolactone) Scaffolds For Homogeneous Bone Tissue Formation

Novel Glycidyl Methacrylated Dextran (Dex-Gma)/gelatin Hydrogel Scaffolds Containing Microspheres Loaded with Bone Morphogenetic Proteins: Formulation and Characteristics

Sustained release poly (lactic-co-glycolic acid) microspheres of bone morphogenetic protein 2 plasmid/calcium phosphate to promote in vitro bone formation and in vivo ectopic osteogenesis.

Release of Bioactive BMP from Dextran-Derived Microspheres: a Novel Delivery Concept.